Anemia - Iron-Deficiency (Pediatric) Guideline References

Malaysia
Search
Sign In

Paediatrics Search

Paediatrics

Paediatrics

Home News Diseases Conferences Special Reports Multimedia

anemia%20-%20iron-deficiency%20(pediatric)

ANEMIA - IRON-DEFICIENCY (PEDIATRIC)

Iron deficiency (ID) is the most common nutritional deficiency in children & reportedly 3x more common than iron-deficiency anemia, but does not always develop into anemia.

Neonates & children may have delayed growth & development; adolescents may show decrements of learning such as behavioral abnormalities.

Iron-deficiency anemia is the most advanced stage of iron deficiency resulted from a protracted imbalance between iron intake & demand.

Characterized by low hemoglobin & hematocrit levels, reduction or depletion of iron stores, low serum iron levels & decreased transferrin saturation.

REFERENCES

Goddard AF, James MW, McIntyre AS, Scott BB; British Society of Gastroenterology. Guidelines for the management of iron deficiency anaemia. Gut. 2011 Oct;60(10):1309-1316. doi: 10.1136/gut.2010.228874. PMID: 21561874
Hadi F. Iron supplementation and therapy for children: simple measures to achieve brighter generation. MIMS. http://staging.pubportal.mims.com/topic/iron-supplementation-and-therapy-for-children--simple-measures-to-achieve-brighter-generation?country=singapore&channel=paediatrics&topicGrouper=. Dec 2015.
Baker RD, Greer FR; Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics. 2010 Nov;126(5):1040-1050. doi: 10.1542/peds.2010-2576. PMID: 20923825
Lichtin A. Iron-deficiency anemia. First Consult. https://www.clinicalkey.com/#!/content/medical_topic/21-s2.0-1014692. Oct 2012.
Mahoney DH. Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis. UpToDate. http://www.uptodate.com/contents/iron-deficiency-in-infants-and-young-children-screening-prevention-clinical-manifestations-and-diagnosis. Jun 2016.
National Health and Medical Research Council (NHMRC), Department of Health and Ageing, Australia. Nutrient reference values for Australia and New Zealand: including recommended dietary intakes. NHMRC. https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/n35.pdf. Sep 2005.
National Institutes of Health. Iron: dietary supplement fact sheet. NIH. https://ods.od.nih.gov/factsheets/Iron-HealthProfessional/#h2. Feb 2016.
Santiago P. Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overview. ScientificWorldJournal. 2012 May;2012(846824). doi: 10.1100/2012/846824. PMID: 22654638
Schrier S, Auerbach M. Treatment of iron deficiency anemia in adults. UpToDate. http://www.uptodate.com/contents/treatment-of-iron-deficiency-anemia-in-adults. Jul 2016.
Short MW, Domagalski JE. Iron deficiency anemia: evaluation and management. Aust Fam Physician. 2013 Jan;87(2):98-104. http://www.aafp.org/afp/2013/0115/p98.html. PMID: 23317073
Vehapoglu A, Ozgurhan G, Demir AD, et al. Hematological indices for differential diagnosis of Beta thalassemia trait and iron deficiency anemia. Anemia. 2014;2014(576738). doi: 10.1155/2014/576738. PMID: 24818016
World Health Organization. Guideline: Daily iron supplementation in infants and children. Geneva: World Health Organization Press; 2016.

Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!

Anastrozole delays bone maturation in kids with congenital adrenal hyperplasia

Yesterday

The aromatase inhibitor anastrozole shows promise in the treatment of children with congenital adrenal hyperplasia, reducing bone age advancement without adversely affecting bone mineral density and visceral adipose tissue, as shown in a recent study.

Enzalutamide shows potential survival benefit in metastatic hormone-sensitive prostate cancer

Roshini Claire Anthony, 6 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.